Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 43 (RPL7AP43)

Target
RPL7AP43
Molecular classification
Other
01

Overview

Ribosomal protein L7a pseudogene 43 (RPL7AP43) is one of many processed pseudogenes derived from the ribosomal protein L7a gene (RPL7A). RPL7A is part of the 60S subunit of the ribosome and plays a role in protein synthesis, but pseudogenes like RPL7AP43 do not encode functional proteins and are considered non-coding sequences without known biological function or disease association. Processed pseudogenes are a common feature of ribosomal protein genes, but they are generally not considered biologically active and do not serve as drug targets or biomarkers[4][6]. RPL7AP43 is explicitly described as a pseudogene[6]. Pseudogenes, including this one, lack functional protein products and are not therapeutic targets[4]. The parent gene, RPL7A, is a ribosomal protein involved in protein synthesis and has some disease associations (e.g., with Diamond-Blackfan anemia[1]), but those functions and associations do not extend to its pseudogenes. Key point: RPL7AP43 is not a receptor, active gene, or drug target, but instead a non-coding pseudogene.

Other names
RPL7A_17_815RPL7AP43

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 43 (RPL7AP43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 43 (RPL7AP43).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call